{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:05:02Z","timestamp":1774893902658,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.178","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T12:59:47Z","timestamp":1399553987000},"page":"e1214-e1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium"],"prefix":"10.1038","volume":"5","author":[{"given":"O V","family":"Leontieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z N","family":"Demidenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M V","family":"Blagosklonny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"BFcddis2014178_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2337\/db11-1300","volume":"61","author":"N Barzilai","year":"2012","unstructured":"Barzilai N, Huffman DM, Muzumdar RH, Bartke A . The critical role of metabolic pathways in aging. Diabetes 2012; 61: 1315\u20131322.","journal-title":"Diabetes"},{"key":"BFcddis2014178_CR2","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4161\/cc.9.15.12458","volume":"9","author":"A Haselton","year":"2010","unstructured":"Haselton A, Sharmin E, Schrader J, Sah M, Poon P, Fridell YW . Partial ablation of adult Drosophila insulin-producing neurons modulates glucose homeostasis and extends life span without insulin resistance. Cell Cycle 2010; 9: 3063\u20133071.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2006.05.013","volume":"4","author":"N Luong","year":"2006","unstructured":"Luong N, Davies CR, Wessells RJ, Graham SM, King MT, Veech R et al. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab 2006; 4: 133\u2013142.","journal-title":"Cell Metab"},{"key":"BFcddis2014178_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.18632\/aging.100208","volume":"2","author":"MM Rahman","year":"2010","unstructured":"Rahman MM, Stuchlick O, El-Karim EG, Stuart R, Kipreos ET, Wells L . Intracellular protein glycosylation modulates insulin mediated lifespan in C. elegans. Aging (Albany NY) 2010; 2: 678\u2013690.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR5","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1038\/cddis.2013.506","volume":"4","author":"MV Blagosklonny","year":"2013","unstructured":"Blagosklonny MV . TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death Dis 2013; 4: e964.","journal-title":"Cell Death Dis"},{"key":"BFcddis2014178_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN . TOR signaling in growth and metabolism. Cell 2006; 124: 471\u2013484.","journal-title":"Cell"},{"key":"BFcddis2014178_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","volume":"40","author":"S Sengupta","year":"2010","unstructured":"Sengupta S, Peterson TR, Sabatini DM . Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010; 40: 310\u2013322.","journal-title":"Mol Cell"},{"key":"BFcddis2014178_CR8","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.4161\/cc.22632","volume":"11","author":"RV Duran","year":"2012","unstructured":"Duran RV, Hall MN . Glutaminolysis feeds mTORC1. Cell Cycle 2012; 11: 4107\u20134108.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","volume":"23","author":"M Cornu","year":"2013","unstructured":"Cornu M, Albert V, Hall MN . mTOR in aging, metabolism, and cancer. Curr Opin Genet Dev 2013; 23: 53\u201362.","journal-title":"Curr Opin Genet Dev"},{"key":"BFcddis2014178_CR10","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.4161\/cc.7.21.6919","volume":"7","author":"ZN Demidenko","year":"2008","unstructured":"Demidenko ZN, Blagosklonny MV . Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7: 3355\u20133361.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.18632\/aging.100040","volume":"1","author":"MV Blagosklonny","year":"2009","unstructured":"Blagosklonny MV, Hall MN . Growth and aging: a common molecular mechanism. Aging (Albany NY) 2009; 1: 357\u2013362.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.4161\/cc.20683","volume":"11","author":"M Kolesnichenko","year":"2012","unstructured":"Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P . Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012; 11: 2391\u20132401.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.exger.2012.08.013","volume":"47","author":"CA Hinojosa","year":"2012","unstructured":"Hinojosa CA, Mgbemena V, Van Roekel S, Austad SN, Miller RA, Bose S et al. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol 2012; 47: 958\u2013965.","journal-title":"Exp Gerontol"},{"key":"BFcddis2014178_CR14","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.1073\/pnas.1002298107","volume":"107","author":"ZN Demidenko","year":"2010","unstructured":"Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV . Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107: 9660\u20139664.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014178_CR15","doi-asserted-by":"publisher","first-page":"13314","DOI":"10.1073\/pnas.1205690109","volume":"109","author":"OV Leontieva","year":"2012","unstructured":"Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV . Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 2012; 109: 13314\u201313318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014178_CR16","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.4161\/cc.22937","volume":"11","author":"OV Leontieva","year":"2012","unstructured":"Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV . Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11: 4642\u20134649.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR17","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.4161\/cc.10.21.18128","volume":"10","author":"JA Menendez","year":"2011","unstructured":"Menendez JA, Vellon L, Oliveras-Ferraros C, Cufi S, Vazquez-Martin A . mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011; 10: 3658\u20133677.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.stem.2012.06.007","volume":"11","author":"R Iglesias-Bartolome","year":"2012","unstructured":"Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, Molinolo AA, Mitchell JB et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 2012; 11: 401\u2013414.","journal-title":"Cell Stem Cell"},{"key":"BFcddis2014178_CR19","first-page":"ra75","volume":"2","author":"C Chen","year":"2009","unstructured":"Chen C, Liu Y, Zheng P . mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009; 2: ra75.","journal-title":"Sci Signal"},{"key":"BFcddis2014178_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431: 200\u2013205.","journal-title":"Nature"},{"key":"BFcddis2014178_CR21","doi-asserted-by":"crossref","first-page":"38052","DOI":"10.1074\/jbc.M106703200","volume":"276","author":"F Tremblay","year":"2001","unstructured":"Tremblay F, Marette A . Amino acid and insulin signaling via the mTOR\/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 2001; 276: 38052\u201338060.","journal-title":"J Biol Chem"},{"key":"BFcddis2014178_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","volume":"30","author":"LS Harrington","year":"2005","unstructured":"Harrington LS, Findlay GM, Lamb RF . Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 2005; 30: 35\u201342.","journal-title":"Trends Biochem Sci"},{"key":"BFcddis2014178_CR23","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1038\/sj.onc.1209885","volume":"25","author":"MN Corradetti","year":"2006","unstructured":"Corradetti MN, Guan KL . Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 2006; 25: 6347\u20136360.","journal-title":"Oncogene"},{"key":"BFcddis2014178_CR24","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011; 332: 1322\u20131326.","journal-title":"Science"},{"key":"BFcddis2014178_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011; 332: 1317\u20131322.","journal-title":"Science"},{"key":"BFcddis2014178_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4161\/cc.27973","volume":"13","author":"OV Leontieva","year":"2014","unstructured":"Leontieva OV, Blagosklonny MV . M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue. Cell Cycle 2014; 13: 509\u2013515.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.18632\/aging.100461","volume":"4","author":"MV Blagosklonny","year":"2012","unstructured":"Blagosklonny MV . Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to. Aging (Albany NY) 2012; 4: 350\u2013358.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.4161\/cc.10.10.15789","volume":"10","author":"ZN Demidenko","year":"2011","unstructured":"Demidenko ZN, Blagosklonny MV . The purpose of the HIF-1\/PHD feedback loop: to limit mTOR-induced HIF-1alpha. Cell Cycle 2011; 10: 1557\u20131562.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajpath.2012.04.018","volume":"181","author":"NG Kolosova","year":"2012","unstructured":"Kolosova NG, Muraleva NA, Zhdankina AA, Stefanova NA, Fursova AZ, Blagosklonny MV . Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats. Am J Pathol 2012; 181: 472\u2013477.","journal-title":"Am J Pathol"},{"key":"BFcddis2014178_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.18632\/aging.100469","volume":"4","author":"XF Zheng","year":"2012","unstructured":"Zheng XF . Chemoprevention of age-related macular regeneration (AMD) with rapamycin. Aging (Albany NY) 2012; 4: 375\u2013376.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/BJ20101024","volume":"431","author":"LR Pearce","year":"2010","unstructured":"Pearce LR, Alton GR, Richter DT, Kath JC, Lingardo L, Chapman J et al. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J 2010; 431: 245\u2013255.","journal-title":"Biochem J"},{"key":"BFcddis2014178_CR32","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1096\/fj.08-109041","volume":"22","author":"FH Einstein","year":"2008","unstructured":"Einstein FH, Fishman S, Bauman J, Thompson RF, Huffman DM, Atzmon G et al. Enhanced activation of a \u2018nutrient-sensing\u2019 pathway with age contributes to insulin resistance. FASEB J 2008; 22: 3450\u20133457.","journal-title":"FASEB J"},{"key":"BFcddis2014178_CR33","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1210\/en.2004-0921","volume":"146","author":"L Khamzina","year":"2005","unstructured":"Khamzina L, Veilleux A, Bergeron S, Marette A . Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146: 1473\u20131481.","journal-title":"Endocrinology"},{"key":"BFcddis2014178_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbrc.2007.08.004","volume":"362","author":"S Mordier","year":"2007","unstructured":"Mordier S, Iynedjian PB . Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes. Biochem Biophys Res Commun 2007; 362: 206\u2013211.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2014178_CR35","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4161\/cc.10.20.17886","volume":"10","author":"AK Saha","year":"2011","unstructured":"Saha AK, Xu XJ, Balon TW, Brandon A, Kraegen EW, Ruderman NB . Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation? Cell Cycle 2011; 10: 3447\u20133451.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR36","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah OJ, Wang Z, Hunter T . Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 2004; 14: 1650\u20131656.","journal-title":"Curr Biol"},{"key":"BFcddis2014178_CR37","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.2337\/diabetes.54.9.2674","volume":"54","author":"F Tremblay","year":"2005","unstructured":"Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005; 54: 2674\u20132684.","journal-title":"Diabetes"},{"key":"BFcddis2014178_CR38","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2337\/db06-1016","volume":"56","author":"M Krebs","year":"2007","unstructured":"Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P et al. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 2007; 56: 1600\u20131607.","journal-title":"Diabetes"},{"key":"BFcddis2014178_CR39","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310: 1642\u20131646.","journal-title":"Science"},{"key":"BFcddis2014178_CR40","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1158\/0008-5472.CAN-05-3111","volume":"66","author":"G He","year":"2006","unstructured":"He G, Sung YM, Digiovanni J, Fischer SM . Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity. Cancer Res 2006; 66: 1873\u20131878.","journal-title":"Cancer Res"},{"key":"BFcddis2014178_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/MCB.26.1.63-76.2006","volume":"26","author":"A Tzatsos","year":"2006","unstructured":"Tzatsos A, Kandror KV . Nutrients suppress phosphatidylinositol 3-kinase\/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol. 2006; 26: 63\u201376.","journal-title":"Mol Cell Biol."},{"key":"BFcddis2014178_CR42","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.transproceed.2009.06.159","volume":"41","author":"B Vodenik","year":"2009","unstructured":"Vodenik B, Rovira J, Campistol JM . Mammalian target of rapamycin and diabetes: what does the current evidence tell us? Transplant Proc 2009; 41: S31\u2013S38.","journal-title":"Transplant Proc"},{"issue":"Suppl 4","key":"BFcddis2014178_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1463-1326.2008.00952.x","volume":"10","author":"G Leibowitz","year":"2008","unstructured":"Leibowitz G, Cerasi E, Ketzinel-Gilad M . The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes. Diabetes Obes Metab 2008; 10 (Suppl 4): 157\u2013169.","journal-title":"Diabetes Obes Metab"},{"key":"BFcddis2014178_CR44","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1128\/MCB.01695-07","volume":"28","author":"Y Shigeyama","year":"2008","unstructured":"Shigeyama Y, Kobayashi T, Kido Y, Hashimoto N, Asahara S, Matsuda T et al. Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol 2008; 28: 2971\u20132979.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2014178_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1742-7843.2009.00427.x","volume":"105","author":"GR Chang","year":"2009","unstructured":"Chang GR, Wu YY, Chiu YS, Chen WY, Liao JW, Hsu HM et al. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK\/HlJ mice. Basic Clin Pharmacol Toxicol 2009; 105: 188\u2013198.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"BFcddis2014178_CR46","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","volume":"335","author":"DW Lamming","year":"2012","unstructured":"Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335: 1638\u20131643.","journal-title":"Science"},{"key":"BFcddis2014178_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/acel.12097","volume":"12","author":"DW Lamming","year":"2013","unstructured":"Lamming DW, Ye L, Astle CM, Baur JA, Sabatini DM, Harrison DE . Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. Aging Cell 2013; 12: 712\u2013718.","journal-title":"Aging Cell"},{"key":"BFcddis2014178_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.18632\/aging.100576","volume":"5","author":"L Ye","year":"2013","unstructured":"Ye L, Widlund AL, Sims CA, Lamming DW, Guan Y, Davis JG et al. Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance. Aging (Albany NY) 2013; 5: 539\u2013550.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR49","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.4161\/cc.10.24.18595","volume":"10","author":"MV Blagosklonny","year":"2011","unstructured":"Blagosklonny MV . Rapamycin-induced glucose intolerance: Hunger or starvation diabetes. Cell Cycle 2011; 10: 4217\u20134224.","journal-title":"Cell Cycle"},{"key":"BFcddis2014178_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fgene.2012.00177","volume":"3","author":"L Ye","year":"2012","unstructured":"Ye L, Varamini B, Lamming DW, Sabatini DM, Baur JA . Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2. Front Genet 2012; 3: 177.","journal-title":"Front Genet"},{"key":"BFcddis2014178_CR51","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps KD, White MF . Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012; 55: 2562\u20132582.","journal-title":"Diabetologia"},{"key":"BFcddis2014178_CR52","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s00125-004-1662-6","volume":"48","author":"M Ueno","year":"2005","unstructured":"Ueno M, Carvalheira JB, Tambascia RC, Bezerra RM, Amaral ME, Carneiro EM et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1\/2 serine phosphorylation and the mTOR\/p70 S6K pathway. Diabetologia 2005; 48: 506\u2013518.","journal-title":"Diabetologia"},{"key":"BFcddis2014178_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1139\/H07-149","volume":"33","author":"EL Glynn","year":"2008","unstructured":"Glynn EL, Lujan HL, Kramer VJ, Drummond MJ, DiCarlo SE, Rasmussen BB . A chronic increase in physical activity inhibits fed-state mTOR\/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle. Appl Physiol Nutr Metab 2008; 33: 93\u2013101.","journal-title":"Appl Physiol Nutr Metab"},{"key":"BFcddis2014178_CR54","doi-asserted-by":"publisher","first-page":"35375","DOI":"10.1074\/jbc.M806480200","volume":"283","author":"J Zhang","year":"2008","unstructured":"Zhang J, Gao Z, Yin J, Quon MJ, Ye J . S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem 2008; 283: 35375\u201335382.","journal-title":"J Biol Chem"},{"key":"BFcddis2014178_CR55","doi-asserted-by":"publisher","first-page":"e59725","DOI":"10.1371\/journal.pone.0059725","volume":"8","author":"M Rajan","year":"2013","unstructured":"Rajan M, Fagerholm S, J\u0161nsson C, Kj\u00f8lhede P, Turkina M, Str\u00e5lfors P . Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase. PLoS One 2013; 8: e59725.","journal-title":"PLoS One"},{"key":"BFcddis2014178_CR56","doi-asserted-by":"publisher","first-page":"31165","DOI":"10.1074\/jbc.M113.474148","volume":"288","author":"N1 Smadja-Lam\u00e8re","year":"2013","unstructured":"Smadja-Lam\u00e8re N1, Shum M, D\u00e9l\u00e9ris P, Roux PP, Abe J, Marette A . Insulin activates RSK (p90 ribosomal S6 kinase) to trigger a new negative feedback loop that regulates insulin signaling for glucose metabolism. J Biol Chem 2013; 288: 31165\u201331176.","journal-title":"J Biol Chem"},{"key":"BFcddis2014178_CR57","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.coph.2009.07.004","volume":"9","author":"JF Tanti","year":"2009","unstructured":"Tanti JF, Jager J . Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 2009; 9: 753\u2013762.","journal-title":"Curr Opin Pharmacol"},{"key":"BFcddis2014178_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1742-4658.2012.08488.x","volume":"279","author":"E Nyman","year":"2012","unstructured":"Nyman E, Fagerholm S, Jullesson D, Str\u0152lfors P, Cedersund G . Mechanistic explanations for counter-intuitive phosphorylation dynamics of the insulin receptor and insulin receptor substrate-1 in response to insulin in murine adipocytes. FEBS J 2012; 279: 987\u2013999.","journal-title":"FEBS J"},{"key":"BFcddis2014178_CR59","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1096\/fj.07-9261com","volume":"22","author":"C Selman","year":"2008","unstructured":"Selman C, Lingard S, Choudhury AI, Batterham RL, Claret M, Clements M et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 2008; 22: 807\u2013818.","journal-title":"FASEB J"},{"key":"BFcddis2014178_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100554","volume":"5","author":"Y Fang","year":"2013","unstructured":"Fang Y, Bartke A . Prolonged rapamycin treatment led to beneficial metabolic switch. Aging (Albany NY) 2013; 5: 328\u2013329.","journal-title":"Aging (Albany NY)"},{"key":"BFcddis2014178_CR61","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1038\/cddis.2012.202","volume":"4","author":"OV Leontieva","year":"2013","unstructured":"Leontieva OV, Paszkiewicz G, Demidenko ZN, Blagosklonny MV . Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet. Cell Death Dis 2013; 4: e472.","journal-title":"Cell Death Dis"},{"key":"BFcddis2014178_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2337\/diab.41.5.571","volume":"41","author":"H Vuorinen-Markkola","year":"1992","unstructured":"Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H . Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes 1992; 41: 571\u2013580.","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"BFcddis2014178_CR63","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/(SICI)1096-9136(199708)14:3+<S32::AID-DIA442>3.3.CO;2-Y","volume":"14","author":"H Yki-Jarvinen","year":"1997","unstructured":"Yki-Jarvinen H . Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies. Diabet Med 1997; 14 (Suppl 3): S32\u2013S37.","journal-title":"Diabet Med"},{"key":"BFcddis2014178_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/JOE-11-0105","volume":"211","author":"MM Okamoto","year":"2011","unstructured":"Okamoto MM, Anhe GF, Sabino-Silva R, Marques MF, Freitas HS, Mori RC et al. Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver. J Endocrinol 2011; 211: 55\u201364.","journal-title":"J Endocrinol"},{"key":"BFcddis2014178_CR65","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1128\/MCB.22.6.1734-1741.2002","volume":"22","author":"K Salnikow","year":"2002","unstructured":"Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K et al. The regulation of hypoxic genes by calcium involves c-Jun\/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol Cell Biol 2002; 22: 1734\u20131741.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2014178_CR66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4161\/cc.28079","volume":"13","author":"JA Menendez","year":"2014","unstructured":"Menendez JA, Alarc\u00f3n T, Joven J . Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. Cell Cycle 2014; 13: 699\u2013709.","journal-title":"Cell Cycle"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2014178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:30:40Z","timestamp":1672961440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":66,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"alternative-id":["BFcddis2014178"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.178","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]},"assertion":[{"value":"17 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}